BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Staging
332 results:

  • 1. Pre-treatment [
    Chen J; Zhao Y
    Hematology; 2024 Dec; 29(1):2325317. PubMed ID: 38465661
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Central Nervous System lymphoma.
    Schaff L
    Continuum (Minneap Minn); 2023 Dec; 29(6):1710-1726. PubMed ID: 38085895
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic value of serum albumin level in patients with diffuse large B cell lymphoma.
    Chen L; Pan L; Liu T
    Acta Biochim Pol; 2023 Dec; 70(4):767-776. PubMed ID: 38051992
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
    Li J; Wang YC; Lin JY
    Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
    [No Abstract]    [Full Text] [Related]  

  • 5. Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group.
    Ferdinandus J; van Heek L; Roth K; Dietlein M; Eich HT; Baues C; Borchmann P; Kobe C
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):490-495. PubMed ID: 37735258
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [
    Jannusch K; Morawitz J; Schweiger B; Weiss D; Schimmöller L; Minko P; Herrmann K; Fendler WP; Quick HH; Antoch G; Umutlu L; Kirchner J; Bruckmann NM
    Eur Radiol; 2023 Nov; 33(11):8366-8375. PubMed ID: 37338559
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria.
    Winkelmann M; Blumenberg V; Rejeski K; Bücklein VL; Ingenerf M; Unterrainer M; Schmidt C; Dekorsy FJ; Bartenstein P; Ricke J; von Bergwelt-Baildon M; Subklewe M; Kunz WG
    Cancer Imaging; 2023 May; 23(1):44. PubMed ID: 37189191
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours.
    Nanni C; Kobe C; Baeßler B; Baues C; Boellaard R; Borchmann P; Buck A; Buvat I; Chapuy B; Cheson BD; Chrzan R; Cottereau AS; Dührsen U; Eikenes L; Hutchings M; Jurczak W; Kraeber-Bodéré F; Lopci E; Luminari S; MacLennan S; Mikhaeel NG; Nijland M; Rodríguez-Otero P; Treglia G; Withofs N; Zamagni E; Zinzani PL; Zijlstra JM; Herrmann K; Kunikowska J
    Lancet Haematol; 2023 May; 10(5):e367-e381. PubMed ID: 37142345
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessment of Social Vulnerability in Pediatric Head and Neck Cancer Care and Prognosis in the United States.
    Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
    JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinicopathological characteristics and prognosis of non-Hodgkin lymphoma in oral and maxillofacial regions: An analysis of 369 cases].
    Su Q; Peng X; Zhou CX; Yu GY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):13-21. PubMed ID: 36718684
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical and endoscopic characteristics of gastrointestinal mantle cell lymphoma].
    Li HP; Zhang WS; He L; Hu H; Ren MQ; Liu XM; Xu LB; Tuo BG
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(46):3673-3679. PubMed ID: 36509538
    [No Abstract]    [Full Text] [Related]  

  • 12. [A multicenter study on childhood Hodgkin lymphoma treated with HL-2013 regimen in China].
    Nie DM; Yuan Q; Yu Y; Wu CJ; Guo X; Zhang AJ; Wang J; Xiao LY; Weng KZ; Fang YJ; Ju XL; Gao J; Xu ZJ; Yang LC; Liu AG; Gao YJ
    Zhonghua Er Ke Za Zhi; 2022 Nov; 60(11):1172-1177. PubMed ID: 36319153
    [No Abstract]    [Full Text] [Related]  

  • 13. [18F]FDG PET/CT and PET/MR in Patients with Adrenal lymphoma: A Systematic Review of Literature and a Collection of Cases.
    Evangelista L; Crimì F; Visentin A; Voltan G; Trentin L; Lacognata C; Cecchin D; Ceccato F
    Curr Oncol; 2022 Oct; 29(10):7887-7899. PubMed ID: 36290900
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Mid-term efficacy of China Net Childhood lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
    Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
    Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
    [No Abstract]    [Full Text] [Related]  

  • 15. Significant CT dose reduction of 2-[
    Tang S; Hu Y; Zeng J; Li Z; Jiang Y; Li Y; Wang J; Sun H; Wu X; Zhou Y; Zhang X; Zhao Y
    Eur Radiol; 2023 Mar; 33(3):2248-2257. PubMed ID: 36166086
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies.
    Landgren O; Kazandjian D; Roussel M; Jasielec J; Dytfeld D; Anderson A; Kervin TA; Iskander K; McFadden I; Jakubowiak AJ
    Leuk Lymphoma; 2022 Oct; 63(10):2413-2421. PubMed ID: 35549810
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell lymphoma.
    Shen Y; Wang L; Ou J; Wang B; Cen X
    Int J Med Sci; 2022; 19(2):225-232. PubMed ID: 35165508
    [No Abstract]    [Full Text] [Related]  

  • 18. Diagnosis and staging of diffuse large B-cell lymphoma using label-free surface-enhanced Raman spectroscopy.
    Chen X; Li X; Yang H; Xie J; Liu A
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Feb; 267(Pt 1):120571. PubMed ID: 34752994
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?
    Imber BS; Chau KW; Lee J; Lee J; Casey DL; Yang JC; Wijentunga NA; Shepherd A; Hajj C; Qi S; Chelius MR; Hamlin PA; Palomba ML; Joffe E; Zhang Z; Zelenetz AD; Salles GA; Yahalom J
    Blood Adv; 2021 Oct; 5(20):4185-4197. PubMed ID: 34529789
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Non-Hodgkin lymphoma Metabolism.
    Kirsch BJ; Chang SJ; Betenbaugh MJ; Le A
    Adv Exp Med Biol; 2021; 1311():103-116. PubMed ID: 34014537
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.